Ask AI

Search

Updates

Loading...

Home

New Question

Are Multitumor Blood Tests More Hype Than Help?

Answer

Multitumor blood tests, also known as multicancer early detection (MCED) tests, have generated significant interest due to their potential to detect multiple cancer types concurrently using a single blood sample. However, their clinical utility and impact on patient outcomes remain areas of active investigation and debate.

Diagnostic performance

Clinical utility

Challenges and uncertainties

In conclusion, while multitumor blood tests hold promise for early cancer detection, their clinical utility and impact on patient outcomes are not yet fully established. Further research, including randomized clinical trials, is needed to evaluate their benefits, harms, and cost-effectiveness

References

1

J Natl Cancer Inst 2023

Abstract

Study design considerations for trials to evaluate multicancer early detection assays for clinical utility

PubMed
High-impact